Top 15 results related to the keyword tag biologic

Research/Project Funding Opportunity

Posted 2 years ago

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
at Department of Health and Human Services National Institutes of Health in Stati Uniti
0 0 Department of Health and Human Services National Institutes of Health
Research/Project Funding Opportunity

Posted 6 months ago

Notice of Change: Expiration of RFA-NS-24-019: HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
at National Institutes of Health in Stati Uniti
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 10 months ago

Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
at National Institutes of Health in Stati Uniti
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 11 months ago

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
at National Institutes of Health in Stati Uniti
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 11 months ago

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
at National Institutes of Health in Stati Uniti
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 1 year ago

NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
at National Institutes of Health in Stati Uniti
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 1 year ago

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
at National Institutes of Health in Stati Uniti
0 0 National Institutes of Health
Financial Aid Offer

Posted 1 year ago

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
at National Institutes of Health in Stati Uniti
0 0 National Institutes of Health
Research/Project Funding Opportunity

Posted 2 years ago

Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional)
at Department of Health and Human Services National Institutes of Health in Stati Uniti
0 0 Department of Health and Human Services National Institutes of Health
Research/Project Funding Opportunity

Posted 2 years ago

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)
at Department of Health and Human Services National Institutes of Health in Stati Uniti
0 0 Department of Health and Human Services National Institutes of Health
Research/Project Funding Opportunity

Posted 3 years ago

NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)
at Department of Health and Human Services National Institutes of Health in Stati Uniti
0 0 Department of Health and Human Services National Institutes of Health
Research/Project Funding Opportunity

Posted 3 years ago

Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)
at Department of Health and Human Services National Institutes of Health in Stati Uniti
0 0 Department of Health and Human Services National Institutes of Health
Research/Project Funding Opportunity

Posted 3 years ago

Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
at Department of Health and Human Services National Institutes of Health in Stati Uniti
0 0 Department of Health and Human Services National Institutes of Health
Research/Project Funding Opportunity

Posted 3 years ago

Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)
at Department of Health and Human Services National Institutes of Health in Stati Uniti
0 0 Department of Health and Human Services National Institutes of Health
Research/Project Funding Opportunity

Posted 3 years ago

HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)
at Department of Health and Human Services National Institutes of Health in Stati Uniti
0 0 Department of Health and Human Services National Institutes of Health

Discover 15 opportunities in biologic

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer&apos;s Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)

Notice of Change: Expiration of RFA-NS-24-019: HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)

NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

NIDCR Drug, Biologic, Device and/or Procedure Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)

Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional)

CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)

NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)

Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R43/R44 - Clinical Trial Optional)

Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)

Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)

HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed)

Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)